Assessment of disease control rate and safety of sorafenib in targeted therapy for advanced liver cancer

The clinical efficacy and safety of sorafenib in patients with advanced liver cancer (ALC) were evaluated based on transarterial chemoembolization (TACE).

Source: World Journal of Surgical Oncology - April 12, 2024 Category: Cancer & Oncology Authors: Daolin Zeng, Chunlin Yu, Shiyao Chen, Long Zou, Junjun Chen and Linlong Xu Tags: Research Source Type: research